经腋窝乳房增大术的系统综述与荟萃分析:11,686只乳房的安全性与结局
结果显示患者满意度高,包膜挛缩、再干预、感染等并发症发生率低,且与其它切口入路相比无显著差异。
要点
- 经腋窝入路初次乳房增大术并发症发生率低,患者满意度高。
- 与其它切口相比,包膜挛缩、再干预、感染风险无显著差异。
- 血肿、血清肿、假体破裂发生率低,无重大不良事件报告。
核心结论
- 经腋窝入路初次乳房增大术安全有效,并发症发生率与乳晕下及环乳晕切口相当,患者满意度高。
主要发现
- 患者报告满意度在所有研究中均持续很高。
- 经腋窝入路与其它切口在包膜挛缩(RR 0.73;95% CI 0.29-1.88)、再干预(RR 0.74;95% CI 0.41-1.34)、感染(RR 1.00;95% CI 0.14-6.99)方面无显著差异。
- 经腋窝入路队列中,包膜挛缩 pooled 发生率2.3%(95% CI 1.6-3.4),再干预3.3%(95% CI 1.7-6.1),感染0.7%(95% CI 0.4-1.2)。
- 血肿发生率1.4%,血清肿1.4%,假体破裂1%,无重大不良事件报告。
临床怎么用
- 经腋窝入路可作为避免乳房可见瘢痕的可行选择,其安全性与其它切口入路相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast augmentation (BA) is one of the most commonly performed plastic procedures worldwide. The transaxillary approach (TAA) has gained popularity for avoiding visible breast scars. Despite its increasing adoption in the clinical practice and technical refinements, the available evidence on safety and outcomes remains limited and heterogeneous. METHODS: A comprehensive search of MEDLINE, Embase, Scopus, Cochrane, and Web of Science databases was performed up to May 2025. Eligible studies included adult women undergoing primary BA (PBA) with silicone implants via the TAA. Primary outcomes were capsular contracture (CC) and patient-reported satisfaction. Secondary outcomes included infection, reintervention, hematoma, seroma, implant rupture, and other complications. RESULTS: Twenty-two studies comprising 5,843 patients (11,686 breasts) were included. Patient-reported satisfaction was consistently very high across all studies. Meta-analyses showed no significant differences between TAA and other incisions for CC (RR 0.73; 95% CI 0.29-1.88), reintervention (RR 0.74; 95% CI 0.41-1.34), or infection (RR 1.00; 95% CI 0.14-6.99). Within the TAA cohort, pooled incidences were low for all outcomes: CC 2.3% (95% CI 1.6-3.4), reintervention 3.3% (95% CI 1.7-6.1), and infection 0.7% (95% CI 0.4-1.2). Importantly, secondary endpoints also demonstrated uniformly favorable safety, with hematoma (1.4%), seroma (1.4%), and implant rupture (1%) occurring rarely, and no major adverse events reported. CONCLUSIONS: PBA via TAA is a safe and effective technique, with complication rates comparable to inframammary and periareolar incisions and uniformly high satisfaction.
引用
- Gonçalves FGA, Terada BD, da Silva LD, et al. "A Systematic Review and Meta-Analysis of 11,686 Breasts Undergoing Transaxillary Augmentation: Why Leave a Trace When You Can Go Invisible?". Plast Reconstr Surg. 2026. PMID: 41628597. doi:10.1097/PRS.0000000000012863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。